These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38984096)

  • 1. Hyperbilirubinemia in ABO Minor Mismatch Transplantation.
    Liao G; Wei C; Huang Q; Wei M; Li J; Chen Y; Yin X
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024050. PubMed ID: 38984096
    [No Abstract]   [Full Text] [Related]  

  • 2. ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.
    Grube M; Wolff D; Ahrens N; Herzberg PY; Herr W; Holler E
    Clin Transplant; 2016 Nov; 30(11):1457-1465. PubMed ID: 27618621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
    Guru Murthy GS; Logan BR; Bo-Subait S; Beitinjaneh A; Devine S; Farhadfar N; Gowda L; Hashmi S; Lazarus H; Nathan S; Sharma A; Yared JA; Stefanski HE; Pulsipher MA; Hsu JW; Switzer GE; Panch SR; Shaw BE
    Am J Hematol; 2023 Apr; 98(4):608-619. PubMed ID: 36606713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT.
    Brierley CK; Littlewood TJ; Peniket AJ; Gregg R; Ward J; Clark A; Parker A; Malladi R; Medd P
    Bone Marrow Transplant; 2015 Jul; 50(7):931-8. PubMed ID: 25867645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.
    Logan AC; Wang Z; Alimoghaddam K; Wong RM; Lai T; Negrin RS; Grumet C; Logan BR; Zhang MJ; Spellman SR; Lee SJ; Miklos DB;
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):746-54. PubMed ID: 25572032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.
    Worel N; Kalhs P; Keil F; Prinz E; Moser K; Schulenburg A; Mitterbauer M; Mannhalter C; Mayr WR; Schwarzinger I; Höcker P; Lechner K; Greinix HT
    Transfusion; 2003 Aug; 43(8):1153-61. PubMed ID: 12869124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides.
    Shokrgozar N; Tamaddon G
    Int J Hematol Oncol Stem Cell Res; 2018 Oct; 12(4):322-328. PubMed ID: 30774834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.
    Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D
    Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
    Xu C; Bao Y; He Y; Wu M; Zhu J
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cord Blood Carboxyhemoglobin in Detecting Significant Hyperbilirubinemia in Term Neonates with ABO Alloimmunization.
    Tıraş M; Can E; Hamilçıkan Ş
    Am J Perinatol; 2022 Sep; 39(12):1321-1325. PubMed ID: 33395710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of UGT1A1 promoter polymorphism and exon-1 mutations in neonatal jaundice.
    Halis H; Ergin H; Köseler A; Atalay EÖ
    J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2658-2664. PubMed ID: 27842454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ABO-Incompatibility on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation].
    Yang BB; Gan YF; Chen P; Chen Y; Yu K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):535-540. PubMed ID: 28446307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune haemolysis after renal transplantation secondary to ABO minor-mismatch between donor and recipient.
    Jayaranee S; Ramesh P; Nadesan V
    Singapore Med J; 2002 Aug; 43(8):421-2. PubMed ID: 12507029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional ABO Mismatch Is Associated With Elevated Mortality in Hematopoietic Stem Cell Transplantation: Insights From a Single-Center Experience.
    Özkan SG; Kimiaei A; Safaei S; Büyükyatıkçı AA; Sönmezoğlu M; Özkan HA
    Cureus; 2024 Feb; 16(2):e54847. PubMed ID: 38533156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.